Add BrightSurf on Google Email

CNIO researchers propose a new therapeutic target that prevents cell division

Researchers at CNIO's Cell Division & Cancer Group have discovered that the protein Greatwall is essential for preventing mitotic collapse in mammals. By inhibiting Greatwall, cells can no longer divide properly, which may lead to slowed-down cancer growth and potentially reactivated tumour suppressor PP2A

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalProceedings of the National Academy of Sciences·DateOct 8, 2013

Poor nutritional status before bladder operation causes higher risk of complications

A new study by the University of North Carolina School of Medicine has identified low preoperative albumin levels as an independent risk factor for surgical-related health problems after radical cystectomy. Patients with a low albumin level before surgery are 2.1 times more likely to experience complications within 30 days.

SourceAmerican College of Surgeons·JournalJournal of the American College of Surgeons·DateOct 7, 2013

JCI early table of contents for Oct. 1, 2013

Researchers at Emory University discovered that hemin injection causes labored breathing and rapid death in sickle mice, but not in control mice. Hemopexin treatment was effective in preventing hemin-induced lung injury. These findings suggest targeting hemin and TLR4 signaling may be a valuable approach for treating acute chest syndrome.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 1, 2013

The State of Oncology 2013

A new report from ECCO highlights the growing burden of cancer worldwide, with India, China, and Nigeria expected to see dramatic increases in cases due to population growth and lifestyle changes. The report calls for a major public-private partnership to improve cancer care and outcomes globally.

Vaccination with GM2-KLH-QS21 does not improve outcome of melanomas patients in EORTC study

The EORTC trial found that vaccination with GM2/KLH-QS-21 did not improve relapse-free or overall survival rates for patients with stage II melanoma. The vaccine was expected to stimulate antibodies against the GM2 ganglioside, but instead, it led to a higher risk of death and decreased survival rates.

SourceEuropean Organisation for Research and Treatment of Cancer·JournalJournal of Clinical Oncology·DateSep 13, 2013

JCI early table of contents for Sept. 9, 2013

Researchers at Massachusetts General Hospital identify fibroblast growth factor 18 (FGF18) as a predictive marker for poor overall survival in ovarian cancer patients. Overexpression of the gene encoding FGF18 was associated with enhanced tumor blood vessel formation and expression of cancer-promoting cytokines.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 9, 2013

NAMS issues new guidance on vulvovaginal atrophy

The North American Menopause Society (NAMS) has published new guidance for diagnosing and treating vulvovaginal atrophy (VVA), a condition affecting up to 45% of women after menopause. The guidance emphasizes the importance of effective treatments, including simple vaginal lubricants, estrogen therapy, and nonhormonal options.

SourceThe Menopause Society·JournalMenopause·DateAug 29, 2013

Combination drug regimen may benefit patients with hepatitis C

A combination of sofosbuvir and ribavirin achieved high sustained virologic response rates in patients with unfavorable treatment characteristics, including advanced liver disease and high baseline HCV RNA levels. The regimen was well-tolerated and safe, with a lower relapse rate compared to traditional interferon-based therapy.

SourceJAMA Network·JournalJAMA·DateAug 27, 2013

Chronicling cancer experience online can reduce depressive symptoms in breast cancer patients

A UCLA study found that women diagnosed with breast cancer who created personal websites experienced reduced depressive symptoms, improved mood, and increased appreciation for life. The project, Project Connect Online, provided a platform for breast cancer patients to share their experiences and connect with friends and family online.

SourceUniversity of California - Los Angeles·JournalJournal of Clinical Oncology·DateAug 13, 2013

NIH researchers identify therapy that may curb kidney deterioration in patients with rare disorder

Researchers at the National Human Genome Research Institute identified biomarkers of kidney damage and demonstrated that antioxidant therapy protected kidney function in mice. These findings offer new tools for monitoring disease progression and may pave the way for clinical trials for patients with methylmalonic acidemia.

SourceNIH/National Human Genome Research Institute·JournalProceedings of the National Academy of Sciences·DateJul 29, 2013

HIV-associated lymphoma survival has not improved during the antiretroviral therapy era

New study reveals stable survival rates for HIV-associated lymphoma patients during the antiretroviral therapy era. Despite increased incidence and changing demographics, recent diagnosis years are not associated with decreased mortality. The study highlights an ongoing need to improve treatments for this challenging population.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 26, 2013

A first in front line immunity research

Researchers have characterised the binding of IFNβ proteins to cells, providing a breakthrough in understanding immune response mechanisms. This study offers new avenues for developing treatments with reduced side effects and improved effectiveness.

SourceMonash University·JournalNature Immunology·DateJul 21, 2013

Researchers find 2 new methods to determine ALK status

Researchers have developed two new methodologies to determine ALK status in non–small-cell lung cancer (NSCLC) patients. The first method improves IHC assay sensitivity using a novel hapten and tyramide amplification, detecting low levels of ALK protein expression. The second method combines brightfield IHC with in situ hybridization f...

SourceInternational Association for the Study of Lung Cancer·JournalJournal of Thoracic Oncology·DateJul 1, 2013

JCI early table of contents for June 24, 2013

A study finds a link between prenatal ICP and postnatal obesity in offspring, while another investigation reveals genetic changes in preeclampsia and brain inflammation caused by chronic cannabis use. These findings may have implications for understanding and treating metabolic diseases and pregnancy complications.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 24, 2013

Chlamydia promotes gene mutations

Researchers at Max Planck Institute discover Chlamydia promotes gene mutations, impairing DNA damage response and leading to uncontrolled cell growth. The infection can cause chronic damage, increasing risk of cervical and ovarian cancer.

SourceMax-Planck-Gesellschaft·JournalCell Host & Microbe·DateJun 20, 2013